Codexis And Dyadic Sign Enzymes Pact | November 24, 2008 Issue - Vol. 86 Issue 47 | Chemical & Engineering News
Volume 86 Issue 47 | p. 19 | Concentrates
Issue Date: November 24, 2008

Codexis And Dyadic Sign Enzymes Pact

Department: Business

Codexis, a Redwood City, Calif.-based biocatalyst technology developer, has licensed Dyadic International's Chrysosporium lucknowense fungus, or C1, expression system for the large-scale production of enzymes for making biofuels and chemical and pharmaceutical intermediates. Codexis will make an up-front payment of $10 million provided that certain performance criteria are satisfied. Based in Jupiter, Fla., Dyadic produces enzymes and other biomaterials using proprietary fungal strains.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment